Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Discloses key behavioral traits: for companies pulls latest 10-K financials from SEC EDGAR/XBRL, handles off-calendar fiscal years; for drugs pulls FAERS, FDA approval counts, trial counts; results sorted by primary metric; returns paired data with citation URIs. Complements annotations (readOnly, idempotent) with actionable details.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Though somewhat lengthy, every sentence adds value. Front-loaded with example queries and a clear 'always prefer' directive. Structure is logical: examples, purpose, type-specific details, return info. Could be slightly more concise, but not wasteful.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, description adequately covers data sources, sorting, and citation URIs. Explains off-calendar fiscal year handling. Could specify return format in more detail, but overall is sufficient for an agent to understand what to expect.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Adds significant meaning beyond schema: explains that 'type' determines data sources (company→financials, drug→FAERS/FDA/trials), specifies that 'values' for companies are tickers/CIKs and for drugs are names, mentions max 5 and min 2. Schema coverage is 100% but description enriches with real-world context.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states the tool performs side-by-side comparisons of 2–5 companies or drugs, with specific examples like 'compare X and Y' and 'rank these companies'. It distinguishes from sibling tools like entity_profile by saying it replaces 8–15 sequential lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities'. Includes example queries and conditions for use (type company vs drug). Clearly indicates when this tool is appropriate.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

The vast majority of tools are unrelated to GitLab and cover overlapping domains (multiple ask_pipeworx variants, several Polymarket tools, memory tools). Only three GitLab-specific tools exist, and they are distinct from each other, but overall the set is highly heterogeneous and ambiguous.

Naming Consistency2/5

Tool names use a mix of conventions: some are snake_case (ask_pipeworx, search_issues), some are compound nouns (get_project, list_subscriptions), and a few are single words (forget, recall). There is no consistent pattern, making it harder to predict tool names.

Tool Count1/5

Despite the server name 'Gitlab Public', only 3 out of 34 tools are related to GitLab. The remaining 31 tools are a collection of unrelated services (Pipeworx data retrieval, Polymarket betting, memory, AI visibility). This is a severe mismatch between the server's stated purpose and its tool composition.

Completeness1/5

For a GitLab public server, essential tools like project creation, deletion, user management, and merge request handling are completely missing. The Pipeworx tools, while numerous, lack a clear cohesive scope and overlap significantly with each other.